HIF1A and obstructive sleep apnea syndrome: Moreover, as shown in Figure 4, severe OSAHS patients who had got CPAP treatment showed a lower plasma HIF‐1 mRNA level compared with the severe OSAHS patients, suggesting that may serve as potential biomarker for evaluating the therapeutic efficacy for OSAHS.